These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31880924)

  • 1. Unprecedented Properties of Phenothiazines Unraveled by a NDH-2 Bioelectrochemical Assay Platform.
    Nakatani Y; Shimaki Y; Dutta D; Muench SP; Ireton K; Cook GM; Jeuken LJC
    J Am Chem Soc; 2020 Jan; 142(3):1311-1320. PubMed ID: 31880924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of type II NADH:quinone oxidoreductase from Caldalkalibacillus thermarum with an improved resolution of 2.15 Å.
    Nakatani Y; Jiao W; Aragão D; Shimaki Y; Petri J; Parker EJ; Cook GM
    Acta Crystallogr F Struct Biol Commun; 2017 Oct; 73(Pt 10):541-549. PubMed ID: 28994401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revealing the Membrane-Bound Catalytic Oxidation of NADH by the Drug Target Type-II NADH Dehydrogenase.
    Godoy-Hernandez A; Tate DJ; McMillan DGG
    Biochemistry; 2019 Oct; 58(42):4272-4275. PubMed ID: 31592658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steady-state kinetics and inhibitory action of antitubercular phenothiazines on mycobacterium tuberculosis type-II NADH-menaquinone oxidoreductase (NDH-2).
    Yano T; Li LS; Weinstein E; Teh JS; Rubin H
    J Biol Chem; 2006 Apr; 281(17):11456-63. PubMed ID: 16469750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitubercular pharmacodynamics of phenothiazines.
    Warman AJ; Rito TS; Fisher NE; Moss DM; Berry NG; O'Neill PM; Ward SA; Biagini GA
    J Antimicrob Chemother; 2013 Apr; 68(4):869-80. PubMed ID: 23228936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type II NADH:quinone oxidoreductase family: phylogenetic distribution, structural diversity and evolutionary divergences.
    Marreiros BC; Sena FV; Sousa FM; Batista AP; Pereira MM
    Environ Microbiol; 2016 Dec; 18(12):4697-4709. PubMed ID: 27105286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the NDH-2 - HQNO inhibited complex provides molecular insight into quinone-binding site inhibitors.
    Petri J; Shimaki Y; Jiao W; Bridges HR; Russell ER; Parker EJ; Aragão D; Cook GM; Nakatani Y
    Biochim Biophys Acta Bioenerg; 2018 Jul; 1859(7):482-490. PubMed ID: 29621505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the bacterial type II NADH dehydrogenase: a monotopic membrane protein with an essential role in energy generation.
    Heikal A; Nakatani Y; Dunn E; Weimar MR; Day CL; Baker EN; Lott JS; Sazanov LA; Cook GM
    Mol Microbiol; 2014 Mar; 91(5):950-64. PubMed ID: 24444429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium tuberculosis type II NADH-menaquinone oxidoreductase catalyzes electron transfer through a two-site ping-pong mechanism and has two quinone-binding sites.
    Yano T; Rahimian M; Aneja KK; Schechter NM; Rubin H; Scott CP
    Biochemistry; 2014 Feb; 53(7):1179-90. PubMed ID: 24447297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the type 2 NADH:menaquinone oxidoreductases from Staphylococcus aureus and the bactericidal action of phenothiazines.
    Schurig-Briccio LA; Yano T; Rubin H; Gennis RB
    Biochim Biophys Acta; 2014 Jul; 1837(7):954-63. PubMed ID: 24709059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type-II NADH:quinone oxidoreductase from Staphylococcus aureus has two distinct binding sites and is rate limited by quinone reduction.
    Sena FV; Batista AP; Catarino T; Brito JA; Archer M; Viertler M; Madl T; Cabrita EJ; Pereira MM
    Mol Microbiol; 2015 Oct; 98(2):272-88. PubMed ID: 26172206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and Functional insights into the catalytic mechanism of the Type II NADH:quinone oxidoreductase family.
    Marreiros BC; Sena FV; Sousa FM; Oliveira AS; Soares CM; Batista AP; Pereira MM
    Sci Rep; 2017 Feb; 7():42303. PubMed ID: 28181562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 NADH Dehydrogenase Is the Only Point of Entry for Electrons into the Streptococcus agalactiae Respiratory Chain and Is a Potential Drug Target.
    Lencina AM; Franza T; Sullivan MJ; Ulett GC; Ipe DS; Gaudu P; Gennis RB; Schurig-Briccio LA
    mBio; 2018 Jul; 9(4):. PubMed ID: 29970468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of catalysis by type-II NADH:quinone oxidoreductases.
    Blaza JN; Bridges HR; Aragão D; Dunn EA; Heikal A; Cook GM; Nakatani Y; Hirst J
    Sci Rep; 2017 Jan; 7():40165. PubMed ID: 28067272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The two alternative NADH:quinone oxidoreductases from
    Sena FV; Sousa FM; Pereira AR; Catarino T; Cabrita EJ; Pinho MG; Pinto FR; Pereira MM
    Microbiol Spectr; 2024 Jul; ():e0415223. PubMed ID: 39012110
    [No Abstract]   [Full Text] [Related]  

  • 16. The key role of glutamate 172 in the mechanism of type II NADH:quinone oxidoreductase of Staphylococcus aureus.
    Sousa FM; Sena FV; Batista AP; Athayde D; Brito JA; Archer M; Oliveira ASF; Soares CM; Catarino T; Pereira MM
    Biochim Biophys Acta Bioenerg; 2017 Oct; 1858(10):823-832. PubMed ID: 28801048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the mechanism of Type-II NADH: Quinone oxidoreductase from S. aureus.
    Sena FV; Sousa FM; Oliveira ASF; Soares CM; Catarino T; Pereira MM
    Redox Biol; 2018 Jun; 16():209-214. PubMed ID: 29524843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discovery.
    Sellamuthu S; Singh M; Kumar A; Singh SK
    Expert Opin Ther Targets; 2017 Jun; 21(6):559-570. PubMed ID: 28472892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory loop between redox sensing of the NADH/NAD(+) ratio by Rex (YdiH) and oxidation of NADH by NADH dehydrogenase Ndh in Bacillus subtilis.
    Gyan S; Shiohira Y; Sato I; Takeuchi M; Sato T
    J Bacteriol; 2006 Oct; 188(20):7062-71. PubMed ID: 17015645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the inhibitory action of synthetic capsaicin analogues with various NADH-ubiquinone oxidoreductases.
    Satoh T; Miyoshi H; Sakamoto K; Iwamura H
    Biochim Biophys Acta; 1996 Jan; 1273(1):21-30. PubMed ID: 8573592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.